A phase I double-blind, crossover, placebo-controlled trial investigating TM 38837 for the treatment of obesity and type 2 diabetes mellitus.
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2010
At a glance
- Drugs TM 38837 (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors 7TM Pharma
- 15 Nov 2010 New trial record
- 11 Nov 2010 This trial has been successfully completed, according to a 7TM Pharma media release.